MRNS:Marinus Pharmaceuticals Inc Snapshot | Charting | News | Options
$0.30 NASDAQ 6:06p ET
August 7 '24 		Investors Are Invited To Participate In The Marinus Pharmaceuticals Inc Fraud Investigation With The Schal... ACCESSWIRE
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on MRNS
    No News Available
    MRNS Investors Have Opportunity To Join Marinus Pharmaceuticals Inc F...
    5:47p ET August 6 '24 ACCESSWIRE
    Levi & Korsinsky Notifies Marinus Pharmaceuticals, Inc. Investors of ...
    2:20p ET August 5 '24 ACCESSWIRE
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class...
    2:13p ET August 5 '24 Newsfile Corp
    August 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Actio...
    12:48p ET August 5 '24 GlobeNewswire
    Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) Seeki...
    12:46p ET August 5 '24 ACCESSWIRE
    MRNS DEADLINE TODAY: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Mar...
    12:41p ET August 5 '24 Newsfile Corp
    ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on B...
    12:26p ET August 5 '24 Newsfile Corp
    Levi & Korsinsky Announces the Filing of a Securities Class Action on...
    12:19p ET August 5 '24 ACCESSWIRE
    FINAL MRNS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Marinu...
    12:01p ET August 5 '24 ACCESSWIRE
    Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Co...
    11:47a ET August 5 '24 ACCESSWIRE

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.